"The IDH1 Inhibitor Ivosidenib May Slow IDH1-Mutant Glioma Progression."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ivosidenib, an inhibitor of mutant IDH1, was safe and showed early evidence of efficacy in glioma. Click to show full abstract

Ivosidenib, an inhibitor of mutant IDH1, was safe and showed early evidence of efficacy in glioma.

Keywords: ivosidenib; glioma; inhibitor ivosidenib; idh1 inhibitor; idh1

Journal Title: Cancer discovery
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended